Linkedin

Home
Startup Insight
Stories
Articles
Features

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Password recovery

Recover your password

your email

Search

Home Tags Human Immunology Biosciences

Human Immunology Biosciences

Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, as well as existing investors Jeito Capital and ARCH Venture Partners.

[Funding alert]HI-Bio Raises $95 Mn Series B Funding to Advance Targeted...

Startuprise io - January 5, 2024

ABOUT US

Startup Rise - USA is rapidly growing business media platform for entrepreneurs and startups to cover and publish their journeys through Video Talks, Interviews, Articles and News.

Contact us: contact@startuprise.io

FOLLOW US

© Copyright Startup Rise USA 2025 All Rights Reserved.

Newsletter

Subscribe to our weekly newsletter and don't forget to check out the latest updates.

EmailEnter your email address

Thanks, I’m not interested